Polymorphism of metabolizing genes and lung cancer histology: Prevalence of CYP2E1 in adenocarcinoma

Cancer Letters

Volumn 112, Issue 1, 1997, Pages 71-78

  El Zein, Randa A ^a   Zwischenberger, Joseph B ^a   Abdel Rahman, Sherif Z ^a   Sankar, Aravind B ^a   Au, William W ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

CYP2E1; Genes; Genetic polymorphism; GSTM1; GSTT1; Histology; Lung cancer; Molecular epidemiology; Smoking

Indexed keywords

CYTOCHROME P450 ISOENZYME; DNA; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED; CYTOCHROME P-450 CYP2E1; DISEASE SUSCEPTIBILITY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0031031785     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04547-8     Document Type: Article

References (39)

1. IARC (1986) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38: Tobacco Smoking. International Agency for Research on Cancer, Lyon.
2. Ooi, W.L., Elston, R.C., Chen, V.W., Bailey-Wilson, J.E. and Rothschild, H. (1986) Increased familial risk for lung cancer, J. Natl. Cancer Inst., 76, 217-222.
3. Hirvonen, A. (1995) Genetic factors in individual responses to environmental exposures, JOEM, 37, 37-43.
4. Harris, C.C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res. Suppl., 51, 5023s-5044s.
5. Rannug, A., Alexandrie, A.-K., Person, I. and Ingelman-Sundberg, M. (1995) Genetic polymorphism of cytochrome P450 1A1, 2D6 and 2E1: regulation and toxicological significance, JOEM, 37. 25-36.
6. Ingelman-Sundberg, M., Johansson, I., Persson, I., Yue, Q.-Y., Dahl, M., Bertilsson, L. and Sjöqvist, F. (1992) Genetic polymorphism of cytochromes P450: interethnic differences and relationship to incidence of lung cancer, Pharmacogenetics, 2, 264-271.
7. Raunio, H., Husgafuel-Persianien, K., Anttila, S., Heitanen, E., Hirvonen, A. and Pelkonen, O. (1995) Diagnosis of polymorphism in carcinogen-activating and inactivating enzymes and cancer susceptibility: a review, Gene, 159, 113-121.
8. Hayashi, S., Watanabe, J. and Kawajirui, K. (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450 IIE1 gene, J. Biochem., 100, 559-564.
9. Kato, S., Shields, P.G., Caporaso, N.E., Hoover, R.N., Trump, B.F., Sugimura, H., Weston, A. and Harris, C.C. (1992) Cytochrome P450 IIE1 genetic polymorphism racial variation and lung cancer risk, Cancer Res., 52, 6712-6715.
10. Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I., Ohmachi, T., Wakui, A., Kanamaru, R. and Wantanabe, M. (1991) Association between restriction fragment length polymorphism of the human cytochrome P450 IIE1 gene and susceptibility to lung cancer, Jpn. J. Cancer Res., 87, 254-256.
11. Persson, I., Johansson, I., Bergling, H., Dahl, M.L., Seidegard, J., Rylander, R., Rannug, A., Hogberg, J. and Ingelman-Sundberg, M. (1993) Genetic polymorphism of cytochrome P450 IIE1 in a Swedish population. Relation to incidence of lung cancer. FEES Lett., 319, 207-211.
12. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A. and Vainio, H. (1993) The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population, Carcinogenesis, 14, 85-88.
13. Board, P., Coggan, M., Johnston, P., Ross, V. and Suzuki, T. (1990) Genetic heterogeneity of the human glutathione S-transferases: a complex of gene families, Pharmacol. Ther., 48, 357-369.
14. Seidegard, J., Pero, R.W., Markowitz, M.M., Roush, G., Miller, D.G. and Beattie, E.J. (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for susceptibility of lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
15. Hirvonen, A., Husgafvel-Pursianien, K., Anttila, S. and Vainio, H. (1993) The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung, Carcinogenesis, 14, 1479-1481.
16. Bell, D.A., Thompson, C.L., Taylor, J., Miller, C.R., Perera, F., Hsieh, L.L. and Lucier, G.W. (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase μ, Environ. Health Perspect., 98, 113-117.
17. Brockmoller, J., Kerb, R., Drakoulis, N., Nitz, M. and Roots, I. (1993) Genotype and phenotype of glutathione S-transferase class μ isoenzyme μ and i in lung cancer patients and controls, Cancer Res., 53, 1004-1011.
18. Pemble, S., Schroeder, K.R., Spencer, S.R., Meyer, D.J., Hallier, E., Bolt, H.M., Ketterer, B. and Taylor, J.B. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of agenetic polymorphism, Biochem. J., 300, 271-276.
19. Weincke, J.K., Pemble, S., Ketterer, B. and Kelsey, K.T. (1995) Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis, Cancer Epidemiol. Biomarkers Prev., 4, 253-259.
20. Chenevix-Trench, G., Young, J., Coggan, M. and Board, P. (1995) Glutathione S-transferase Ml and Tl polymorphisms: susceptibility to colon cancer and age of onset, Carcinogenesis, 16, 1655-1657.
21. Trizna, Z., Clayman, G.L., Spitz, M.R., Briggs, K.L. and Goepfert, H. (1995) Glutathione S-transferase genotypes as risk factors for head and neck cancer, Am. J. Surg., 170, 499-501.
22. Nelson, H.H., Wiencke, J.K., Christiani, D.C., Cheng, T.J., Zuo, Z.-F., Schwartz, B.C., Lee, B.-K., Spitz, M.R., Wang, M., Xu, X. and Kelsey, K.T. (1995) Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta, Carcinogenesis, 16, 1243-1245.
23. El-Zein, R.A., Abdel-Rahman, S.Z., Zwischenberger, J.B. and An, W.W. (1995) Genetic polymorphism in cytochrome P450 2E1 and glutathione S-transferase Ml genes: factors implicated in lung cancer risk, Environ. Mol. Mutagenesis (Suppl.), 25, 59.
24. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn., pp. 9,19-E,19. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Bell, D.A., Taylor, J.A., Paulson, D., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen metabolism gene glutathione transferase μ (GSTM1) increases susceptibility to bladder cancer, J. Natl. Cancer. Inst., 85, 1159-1164.
26. Idle, J. (1991) Is environmental carcinogenesis modulated by host polymorphism?, Mutat. Res., 47, 259-266.
27. Bartch, H., Oshima, H., Pagnatelli, B. and Calmems, S. (1992) Endogenously formed nitroso-compounds and nitrosing agents in human cancer etiology, Pharmacogenetics, 2, 272-277.
28. Anwar, W.A., Abdel-Rahman, S.Z., El-Zein, R.A., Mostafa, H.M. and Au, W.W. (1996) Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis, in press.
29. El-Zein, R.A., Abdel-Rahman, S.Z., Sankar, A.B., Zwischenberger, J.B. and Au, W.W. (1996) Genetic polymorphism and risk for development of lung cancer, Environ. Mol. Mutagenesis (Suppl.), 27, 20.
30. Kivisto, K.T., Linder, A., Friedek, G., Beaune, P., Belloc, C., Kroemer, H.K. and Fritz, P. (1995) Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue, Virchows Arch., 426, 243-247.
31. Guengerich, F.P., Kim, D.-H. and Iwasaki, M. (1991) Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects, Chem. Res. Toxicol., 4, 168-179.
32. Anttila, S., Heitanen, E., Vainio, H., Camus, A.-M., Gelboin, H.V., Park, S.S., Heikkila, L., Karjalainen, A. and Bartsch, H. (1991) Smoking and peripheral types of cancer are related to high levels of pulmonary cytochrome P450Ia in lung cancer patients, Int. J. Cancer, 47, 681-685.
33. Zhong, S., Howie, A.F., Ketterer, B., Taylor, J., Hayes, J.D., Beckett, G.J., Wathen, C.G., Wolf, C.R. and Spurr, N.K. (1991) Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility, Carcinogenesis, 12, 1533-1537.
34. Nakajima, T., Elvoraara, E., Anttila, S., Hirvonen, A., Camus, A.-M., Hayes, J.D., Ketterer, B. and Vainio, H. (1995) Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer, Carcinogenesis, 16, 707-711.
35. Anttila, S., Hirvonen, A., Vainio, H., Husgafvel-Pursianinen, K., Hayes, J.D. and Ketterer, B. (1993) Immunohistochemical localization of glutathione S-transferases in human lung, Cancer Res., 53, 5643-5648.
36. 32P-postlabelling assay, J. Natl. Cancer Inst., 81, 341-347.
37. Lafuente, A., Pujol, F., Carretero, P., Villa, J.P. and Cuch, A. (1993) Human glutathione S-transferase (GST μ) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers, Cancer Lett., 68, 49-54.
38. Abdel-Rahman, S.Z., El-Zein, R.A., Anwar, W.A. and Au, W.W. (1996) A multiplex PCR procedure for genetic polymorphism of GSTM1 and GSTT1 genes in population studies. Cancer Lett., in press.
39. Hallier, E., Langhof, T., Dannappel, D., Leutbecher, M., Schroeder, K., Goergens, H.W., Muller, A. and Bolt, H.M. (1993) Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes, Arch. Toxicol., 67, 173-178.